RECOGNITION AND ASSESSMENT

Symptoms and signs

  • >1 watery, loose or unformed stools within 24 hr
  • ± signs of colitis

Risk factors

  • Gastric acid suppression
  • Advanced age,
  • Prior hospitalisation,
  • Duration of hospitalisation
  • Care home residency
  • Abdominal surgery
  • Nasogastric tube

INITIAL MANAGEMENT

Laxative or antibiotic treatment

  • If the diarrhoea may be caused by laxative or antibiotic
    • stop laxative and, if possible, stop antibiotics
    • for 24 hr follow impact on diarrhoea
  • If the diarrhoea stops, do not submit a stool sample
  • If the diarrhoea continues, send diarrhoeal stool sample

New unexplained diarrhoea

  • Isolate patient with in a side room (any ward) within 2 hr
  • Send diarrhoeal stool sample .
  • If necessary, promptly escalate to site manager

Investigations

  • FBC for WBC↑
  • U&E

Stool sample for microbiology

  • A diarrhoeal sample is a stool taking the shape of the container
  • The laboratory will not test formed stool
  • Interpretation is provided with all test reports

Colitis

  • Signs of colitis: X-rays/CT scan abdomen
  • Lower gastrointestinal endoscopy for tissue biopsy
    • invasive
    • in severe colitis may increase the risk of perforation
    • in case of doubt about diagnosis, contact gastroenterologist

CONFIRMED CDI MANAGEMENT

  • Confirmed=Stool C. difficile GDHA positive with TEIA or PCRG positive

Management

  • Nurse in single room (any ward)/C. difficile cohort ward
  • Contact infection prevention team (IPT)
  • Avoid successive uninterrupted courses of different antimicrobials for any indication
Treatment tool
Bristol-stool-chart

cdi-flowchart

SUBSEQUENT MANAGEMENT

  • Nurse patient in side room/cohort ward until symptom-free for 72 hr
  • If another cause identified, discuss with microbiologist/ID consultant
  • If mild/moderate CDI deteriorates, or if diarrhoea fails to respond to antimicrobial treatment of CDI for>5 days, discuss with microbiologist/ ID consultant

Repeat stool samples

  • Unless diagnosis in doubt, do not send repeat stool within 72 hr
  • If GDHA and TEIA positive, do not send further stool for CDI testing within 28 days
    • stool can remain toxin positive for several weeks

Recurrence/non-responder

  • Keep in side-room irrespective of symptoms until the first of:
    • hospital discharge or
    • 6 months have elapsed since last CDI diagnosis
  • Review any current antimicrobial treatment and if possible, stop
  • If life-threatening colitis, refer to GI surgeons for consideration of colectomy
  • First recurrence within 6 months, or if no response to oral vancomycin within 2–5 days:
    • treat with fidaxomicin 200 mg 12-hrly for 10 days
  • Subsequent recurrence within 6 months (3rd or further episode of CDI):
    • consider HPI
    • otherwise, commence fidaxomicin 200 mg 12-hrly, to be given for 10 days

Faecal Microbiota Transplant (FMT) Infusion

  • Infusion of a filtrate of gut flora derived from healthy donor faeces
  • Patients with recurrent CDI treated with HPI demonstrated:
    • 91% primary cure rate with symptoms usually resolving within 48 hr
    • reduced risk of recurrent CDI in the following months provided that the patient does not receive further antibiotics
  • Consider HPI for a 3rd or further episode of CDI

Administration

  • Obtain patient’s consent
  • Contact microbiologist
  • Complete HPI order form for microbiologist to order from the PHE laboratory
  • Preparation of stool from pre-screened universal donors will arrive in 3–4 days
  • Stop all antibiotic treatment (including for CDI) on the day before HPI is to be administered
  • Prepare patient for administration
    • via nasogastric, naso-jejunal tube or PEG,
    • if other routes are not an option, via colonic infusion by a gastroenterologist